Recent advances in LC‐MS‐based metabolomics for clinical biomarker discovery
Mass Spectrometry Reviews · 2023-11 · 42 (6) · 2349-2378
DOI: 10.1002/mas.21785 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Mass Spectrometry Reviews, online erschienen am 29.05.2022. Verfasst von Chao-Jung Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Integrated Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan. Die Arbeit wurde bisher 159-mal zitiert (Crossref) und nennt 137 Literaturangaben.
Abstract (Originalsprache)
The employment of liquid chromatography‐mass spectrometry (LC‐MS) untargeted and targeted metabolomics has led to the discovery of novel biomarkers and improved the understanding of various disease mechanisms. Numerous strategies have been reported to expand the metabolite coverage in LC‐MS‐untargeted and targeted metabolomics. To improve the sensitivity of low‐abundance or poor‐ionized metabolites for reducing the amount of clinical sample, chemical derivatization methods are used to target different functional groups. Proper sample preparation is beneficial for reducing the matrix effect, maintaining the stability of the LC‐MS system, and increasing the metabolite coverage. Machine learning has recently been integrated into the workflow of LC‐MS metabolomics to accelerate metabolite identification and data‐processing automation, and increase the accuracy of disease classification and clinical outcome prediction. Due to the rapidly growing utility of LC‐MS metabolomics in discovering disease markers, this review will address the recent advances in the field and offer perspectives on various strategies for expanding metabolite coverage, chemical derivatization, sample preparation, clinical disease markers, and machining learning for disease modeling.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Graduate Institute of Integrated Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan.
- Proteomics Core Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan.
- AI Innovation Center, China Medical University Hospital, Taichung, Taiwan.
Zitieren
APA
Chen, C. J., Lee, D. Y., Yu, J., Lin, Y. N., & Lin, T. M. (2023). Recent advances in LC‐MS‐based metabolomics for clinical biomarker discovery. Mass Spectrometry Reviews, 42(6), 2349-2378. https://doi.org/10.1002/mas.21785
Vancouver
Chen CJ, Lee DY, Yu J, Lin YN, Lin TM. Recent advances in LC‐MS‐based metabolomics for clinical biomarker discovery. Mass Spectrometry Reviews. 2023;42(6):2349-2378. doi:10.1002/mas.21785
BibTeX
@article{Chen2023,
author = {Chen, Chao-Jung and Lee, Der-Yen and Yu, Jiaxin and Lin, Yu-Ning and Lin, Tsung-Min},
title = {Recent advances in LC‐MS‐based metabolomics for clinical biomarker discovery},
journal = {Mass Spectrometry Reviews},
year = {2023},
volume = {42},
number = {6},
pages = {2349--2378},
doi = {10.1002/mas.21785}
}
EUVIMED